We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Billon have created a technology that enables zero cost global payments by the use of a simple mobile app. Billon's mobile app allows you to instantly pay for the rest of an article from the Guardian or even donate to your favourite Youtubers with a few clicks of a button. 
days to go: Expired investment: £1,406,667
SpaceX is an aerospace manufacturer and space transportation services company founded in 2002 by Elon Musk that aims to reduce space transportation costs and eventually enable the colonisation of Mars. The company has developed several launch vehicles, rocket engines and Autonomous Spaceport Drone Ship (ASDS) landing platforms. Its project, Falcon 9, became the first rocket to accomplish a propulsive vertical landing in December 2015. As of March 2018, SpaceX had over 100 launches on its manifest representing about $12 billion (£9.24 billion) in contract revenue. The company has also ventured into providing satellite internet access by launching its Starlink project. As of 13th June 2020, it has launched 540 Starlink satellites. It will soon launch its Interplanetary Transport System (ITS), Starship, to further inter-planetary travel and colonisation. They will use the investment to grow its projects across various verticals.
days to go: Expired investment: £8,752,000
Walljam is a sports technology business that is digitising ball sports through its advanced, smart panel technology. The company's latest offering, 'Metrix', is the first football-themed social entertainment venue launched in partnership with UEFA Champions League. Walljam intends Metrix to be the turning point in the company's image from a purely fan engagement platform to a social entertainment and live events operator. Metrix's inaugural venue will open in Autumn 2020 at Westfield London (White City), Europe’s largest shopping mall. Under the UEFA Global Licensing Partnership, nine more venues are expected to open across Europe within the next five years. The company is seeking to raise funds of £3.5 million at a pre-money valuation of £3.6 million. It will use the investment to launch the first Metrix venue and manage working capital.
days to go: Expired investment: £577,132
Fizzbox is an online marketplace created to sell and organise group booking. This platform also offers customers benefits like free cancellation and booking with just 20% deposit. The company's website has a mission to become the world's largest event company that does not organize events. The company has completed over 1,626 bookings that resulted in £79,000 of commission and £478,000 of revenues in the first year of trading. With the proceeds, the company will complete application development, marketing, recruitment, and fund general working capital.
days to go: Expired investment: Withheld
epaysecure is a secure payment system, which offers comprehensive payment and benefit options, and allows all the services the consumer demands to be offered in one card and e-account. The prepaid business purchasing in European markets is estimated to be $700 million. The company operates in an e-banking and financial services marketing sector that helps clients by identifying new markets and bringing in new ideas to develop them through reloadable products and e-Wallet platform. The funds will be used for staffing, set up costs, other overheads including property marketing and general office costs.

Pitch Rated

73%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £168,340
Ablatus Therapeutics is a MedTech company developing a one-of-a-kind tissue ablation platform known as Bimodal Electric Tissue Ablation (BETA). This technology has been designed to overcome the limitations of existing products by offering ablation solutions in oncology (tumours) as well as non-oncology targets. With the proceeds, the company will finish the final elements of engineering of the generator and probe. It will also deliver formal safety test data that is a prerequisite for subsequent clinical trials.
days to go: Expired investment: Withheld
Warwick Acoustics produces Electrostatic Audio Systems for the auto industry. The company is partnered with various car Original Equipment Manufacturers and Tier 1 suppliers to produce and distribute automotive solutions. 
days to go: Expired investment: Withheld
Founded by entrepreneurs, Oliver Hutley (COO) and Rory Chichester (CEO), TECS Group is an expert provider of technology. TECS Group delivers non-discretionary critical services, such as Electrical Testing and Treatment, Gas Safety, and Fire Safety, on behalf of customers. These services are covered by strict legislation & regulation. Following a constant period of investment into developing a scalable and a solid operating platform, the TECS Group is embarking on its subsequent stage of growth. With the proceeds, the company will deliver and successfully implement its technology strategy, successfully drive for organic sales, increase the national coverage, and continue its final program.
days to go: Expired investment: £96,770
Synergy Grill have developed a grill that cuts gas bills by 50% because air is injected into the combustion. There is also no fat tray with the Synergy Grill, the fat is entirely vapourised and goes back through the food to further enhance the taste.
days to go: Expired investment: £765,000
Ceryx Medical is a medical technological entity that is developing bioelectronics based on a unique, patent-protected, chip technology that can mimic nerve centres within the body called Central Pattern Generators (CPGs). CPGs help to control a range of autonomic or rhythmical processes within the body such as peristalsis, heart rate, and even walking. The Ceryx system resembles a traditional cardiac pacing device that holds a lot of promise in potentially alleviating incidences of heart failure leading to a therapeutic effect on patient health. In the UK, this is a day surgery procedure under local anaesthetic with a basic system costing around £3500. The device, therefore, offers a cost-effective, single procedure solution for this currently intractable disease. Treatment expenditures on heart failure cases in the EU amount to almost £35 billion. The Ceryx system is a potential disruptor in this segment and offers multiple potential applications. The company is targeting £500,000 as part of £1 million round. With the investment, the company aims to produce a data package that mimics those used to support 510k/NDA applications, as mandated by the US Food and Drug Administration (FDA), for current devices and drugs used to treat heart failure.
days to go: Expired investment: Withheld
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph